Is BioNexus Gene Lab Corp. (BGLC) Set To Achieve Price Targets?
The stock of BioNexus Gene Lab Corp. (NASDAQ:BGLC) increased by $0.12 on Friday to finish at $1.30, up 10.17 percent. The last five days have seen an average of 9,664,600 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$10.1000. The average number of shares […]
How BioNexus Gene Lab Corp. (BGLC) Works From A Technical Perspective
BioNexus Gene Lab Corp. (NASDAQ:BGLC) finished Wednesday with an addition of $0.24 to close at $1.62, an upside of 17.39 percent. An average of 20,585,900 shares of common stock have been traded in the last five days. There was a gain of $0.9000 in the past week, and it reached a new high 3 times […]
So Far This Year, BioNexus Gene Lab Corp. (BGLC) Reached A New High 2 times
At the last check on Thursday, BioNexus Gene Lab Corp.’s (NASDAQ:BGLC) stock was up $0.66, moving up 91.67 percent to $1.38. The average number of shares traded per day over the past five days has been 1,704,507 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0250 fall in […]
BioNexus Gene Lab Corp. (BGLC) Shares: Are They Risky Or Cheap?
BioNexus Gene Lab Corp. (NASDAQ:BGLC) finished Wednesday with an addition of $0.07 to close at $1.22, an upside of 6.09 percent. An average of 1,198,680 shares of common stock have been traded in the last five days. There was a fall of -$0.8200 in the past week, and it reached a new high 3 times […]